Protection of homologous and heterologous boosters after primary schemes of rAd26-rAd5, ChAdOx1 nCoV-19 and BBIBP-CorV during the omicron outbreak in adults of 50 years and older in Argentina: a test-negative case–control study

BACKGROUND: After primary vaccination schemes with rAd26-rAd5 (Sputnik V), ChAdOx1 nCoV-19, BBIBP-CorV or heterologous combinations, the effectiveness of homologous or heterologous boosters (Sputnik V, ChAdOx, Pfizer-BioNTech, Moderna) against SARS-CoV-2 infections, hospitalisations and deaths has b...

Descripción completa

Detalles Bibliográficos
Autores principales: González, Soledad, Olszevicki, Santiago, Gaiano, Alejandra, Salazar, Martín, Regairaz, Lorena, Varela Baino, Ana Nina, Bartel, Erika, Varela, Teresa, González Martínez, Veronica V., Pesci, Santiago, Marín, Lupe, Irassar, Juan Ignacio, Ceriani, Leticia, Garcia, Enio, Kreplak, Nicolás, Estenssoro, Elisa, Marsico, Franco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558771/
https://www.ncbi.nlm.nih.gov/pubmed/37808936
http://dx.doi.org/10.1016/j.lana.2023.100607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558771/
https://www.ncbi.nlm.nih.gov/pubmed/37808936
http://dx.doi.org/10.1016/j.lana.2023.100607

Ejemplares similares